Alpha Teknova (Alpha Teknova) Float Percentage Of Total Shares Outstanding : 21.94% (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Teknova Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alpha Teknova's float shares is 8.96 Mil. Alpha Teknova's total shares outstanding is 40.82 Mil. Alpha Teknova's float percentage of total shares outstanding is 21.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alpha Teknova's Insider Ownership is 9.76%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alpha Teknova's Institutional Ownership is 2.93%.

Alpha Teknova Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Alpha Teknova's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	8.96	/	40.82
	=	21.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Teknova (Alpha Teknova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpha Teknova Inc (NAS:TKNO) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2451 Bert Drive, Hollister, CA, USA, 95023

Website

https://www.teknova.com

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Executives

Ken Gelhaus	officer: Chief Commercial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Stephen Gunstream	director, officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
J Matthew Mackowski	director	343 SANSOME ST, SUITE 1215, SANSASAN FRANCISCO CA 94104
Matthew Lowell	officer: Chief Financial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Damon Terrill	officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
Thp Iv Affiliates Fund, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Lisa Hood	officer: Chief People Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Irene Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Ted Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Iv, L.p.	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO MA 94108
Paul David Grossman	director	1600 FARADAY AVENUE, CARLSBAD CA 92008
Brett Robertson	director	C/O INVUITY, INC., 444 DE HARO STREET, SAN FRANCOSCO CA 94107
Alexander C. Herzick	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Management Company, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108